Universal Coronavirus vaccine could save billions in U.S., new study suggests
The epidemiologic, clinical, and economic value of a universal coronavirus disease 2019 (COVID-19) vaccine.
The epidemiologic, clinical, and economic value of a universal coronavirus disease 2019 (COVID-19) vaccine.
A machine-learning (ML) algorithm for predicting oliguria.
The impact of nicotine exposure on host nutritional status, gut microbial metabolites, and metabolic homeostasis.
The accuracy of antibiotic resistance determination from Enterococcus faecium genomes for diagnostic purposes.
Study evaluated the effectiveness of mRNA COVID-19 vaccines (BNT162b2, mRNA-1273, and heterologous schedules) in preventing hospitalization among adolescents in Nordic countries, finding high protection rates of 73% to 86% at…
Study finds bivalent mRNA COVID-19 vaccines are more effective than monovalent vaccines in preventing thromboembolic events in older adults and those with end-stage renal disease.
A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce the economic burden by US…
Sstudy reveals significant immune changes in long COVID patients, including altered T cell responses and systemic inflammation, using advanced 'omics' and serological assays.
Study finds the JN.1 variant of SARS-CoV-2 may not have increased immune escape ability compared to its predecessor BA.2.86, suggesting other factors for its rapid spread.
Study identifies 921 chemicals potentially linked to breast cancer risk, using a framework evaluating genotoxicity and endocrine activity.